Accès membres

Bienvenue sur le site du Groupe d’étude des Tumeurs Endocrines

Le groupe d'étude des tumeurs endocrines est une société savante créée en 2002 réunissant les différentes spécialités impliquées dans la prise en charge des tumeurs neuro-endocrines (TNE) : anatomopathologistes, biologistes, chirurgiens, endocrinologues, gastroentérologues, généticiens, médecins nucléaires, oncologues et radiologues.

Les publications du GTE

par le Dr Régis Cohen (Saint-Denis)

Publications 2017

- Triponez F, Sadowski SM, Pattou F, Cardot-Bauters C, Mirallié E, Le Bras M, Sebag F, Niccoli P, Deguelte S, Cadiot G, Poncet G, Lifante JC, Borson-Chazot F, Chaffanjon P, Chabre O, Menegaux F, Baudin E, Ruszniewski P, Du Boullay H, Goudet P.
Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ?2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study
Ann Surg. 2017 Mar 3. doi: 10.1097/SLA.0000000000002191. [Epub ahead of print]

- Roquin G, Baudin E, Lombard-Bohas C, Cadiot G, Dominguez S, Guimbaud R, Niccoli P, Legoux JL, Mitry E, Rohmer V, Ruszniewski P, Walter T, Ducreux M, Couvelard A, Scoazec JY, Ramond-Roquin A, Caroli-Bosc FX, Hentic O.
Chemotherapy in Well-Differentiated Pancreatic Neuroendocrine Tumours with Ki-67 ?10%: Is there a More Effective Antitumor Regimen A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE).
Neuroendocrinology. 2017 Feb 3. doi: 10.1159/000457955. [Epub ahead of print]

Publications 2015

- Goudet P, Dalac A, Le Bras M, Cardot-Bauters C, Niccoli P, Lévy-Bohbot N, du Boullay H, Bertagna X, Ruszniewski P, Borson-Chazot F, Vergès B, Sadoul JL, Ménégaux F, Tabarin A, Kühn JM, d'Anella P, Chabre O, Christin-Maitre S, Cadiot G, Binquet C, Delemer B
MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'étude des Tumeurs Endocrines.
J Clin Endocrinol Metab. 2015 Apr;100(4):1568-77

- Vezzosi D, Cardot-Bauters C, Bouscaren N, Lebras M, Bertholon-Grégoire M, Niccoli P, Levy-Bohbot N, Groussin L, Bouchard P, Tabarin A, Chanson P, Lecomte P, Guilhem I, Carrere N, Mirallié E, Pattou F, Peix JL, Goere D, Borson-Chazot F, Caron P, Bongard V, Carnaille B, Goudet P, Baudin E.
Long-term results of the surgical management of insulinoma patients with MEN1: a GTE retrospective study
Eur J Endocrinol. 2015 Mar;172(3):309-19

Publications 2014

- Nozières C, Zhang CX, Buffet A, Dupasquier S, Vargas-Poussou R, Guillaud-Bataille M, Cordier-Bussat M, Ruszniewski P, Christin-Maitre S, Murat A, Groussin L, Vezzosi D, Cardot-Bauters C, Hervieu V, Joly MO, Giraud S, Odou MF, Gimenez-Roqueplo AP, Goudet P, Borson-Chazot F, Calender A
p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
Ann Endocrinol (Paris). 2014 Jul;75(3):133-40

Publications 2013

- Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; Société française d’endocrinologie and the Groupe d’étude des tumeurs endocrines.
Malignant insulinoma: Recommendations for characterisation and treatment.

Ann Endocrinol (Paris). 2013 Dec;74(5-6):523-33

- Hescot S, Leboulleux S, Amar L, Vezzosi D, Borget I, Bournaud-Salinas C, de la Fouchardiere C, Libé R, Do Cao C, Niccoli P, Tabarin A, Raingeard I, Chougnet C, Giraud S, Gimenez-Roqueplo AP, Young J, Borson-Chazot F, Bertherat J, Wemeau JL, Bertagna X, Plouin PF, Schlumberger M, Baudin E; French group of Endocrine and Adrenal tumors (Groupe des Tumeurs Endocrines-REseau NAtional des Tumeurs ENdocrines and COrtico-MEdullo Tumeurs Endocrines networks).
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma.
J Clin Endocrinol Metab. 2013 Oct;98(10):4006-12.

- Bernard V, Lombard-Bohas C, Taquet MC, Caroli-Bosc FX, Ruszniewski P, Niccoli P, Guimbaud R, Chougnet CN, Goichot B, Rohmer V, Borson-Chazot F, Baudin E; French Group of Endocrine Tumors.
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
Eur J Endocrinol. 2013 Apr 15;168(5):665-74.

- Bihan H, Murat A, Fysekidis M, Al-Salameh A, Schwartz C, Baudin E, Thieblot P, Borson-Chazot F, Guillausseau PJ, Cardot-Bauters C, Raingeard I, Requeda E, Sadoul JL, Reznik Y; Régis Cohen for the French Group of Endocrine Tumours.
The clinical spectrum of RET proto-oncogene mutations in codon 790.
Eur J Endocrinol. 2013 Jul 29;169(3):271-6.

- Pina G, Dubois S, Murat A, Berger N, Niccoli P, Peix JL, Cohen R, Guillausseau C, Charrie A, Chabre O, Cornu C, Borson-Chazot F, Rohmer V; Groupe des Tumeurs Endocrines.
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Clin Endocrinol (Oxf). 2013 Mar;78(3):358-64.

- Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Parfait B, Chabre O, Castermans E, Beckers A, Ruszniewski P, Le Bras M, Delemer B, Bouchard P, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Penfornis A, Bihan H, Archambeaud F, Kerlan V, Duron F, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P.
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
Hum Mol Genet. 2013 May 15;22(10):1940-8.

- Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; GTE Group.
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi: 10.1210/jc.2012-2789. Epub 2013 Jan 4. Erratum in: J Clin Endocrinol Metab. 2013 Apr;98(4):1766.

Publications 2012

- Garby L, Caron P, Claustrat F, Chanson P, Tabarin A, Rohmer V, Arnault G, Bonnet F, Chabre O, Christin-Maitre S, du-Boullay H, Murat A, Nakib I, Sadoul JL, Sassolas G, Claustrat B, Raverot G, Borson-Chazot F; GTE Group.
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
J Clin Endocrinol Metab. 2012 Jun;97(6):2093-104. Epub 2012 Mar 22

- Speisky D, Duces A, Bièche I, Rebours V, Hammel P, Sauvanet A, Richard S, Bedossa P, Vidaud M, Murat A, Niccoli P, Scoazec JY, Ruszniewski P, Couvelard A; GTE Group, Groupe d'Etude des Tumeurs Endocrines
Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Clin Cancer Res. 2012 May 15;18(10):2838-49. Epub 2012 Mar 29.

- Barbe C, Murat A, Dupas B, Ruszniewski P, Tabarin A, Vullierme MP, Penfornis A, Rohmer V, Baudin E, Le Rhun M, Gaye D, Marcus C, Cadiot G; for the Groupe d’étude des Tumeurs Endocrines (GTE).
Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1
Dig Liver Dis. 2012 Mar;44(3):228-34. Epub 2011 Nov 11.

- Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V, Young J, Delemer B, Du Boullay H, Verger MF, Kuhn JM, Sadoul JL, Ruszniewski P, Beckers A, Monsaingeon M, Baudin E, Goudet P, Tabarin A.
Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.
Eur J Endocrinol. 2012 Feb;166(2):269-79. Epub 2011 Nov 14

Publications 2011

- Le Roux C, Lombard-Bohas C, Delmas C, Dominguez-Tinajero S, Ruszniewski P, Samalin E, Raoul JL, Renard P, Baudin E, Robaskiewicz M, Mitry E, Cadiot G; Groupe d'étude des Tumeurs Endocrines (GTE).
Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.
Dig Liver Dis. 2011 Oct;43(10):828-33. Epub 2011 Jun 8.

- Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Ménégaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Cadiot G, Beckers A, Guilhem I, Chabre O, Caron P, Du Boullay H, Verges B, Cardot-Bauters C.
Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
Eur J Endocrinol. 2011 Jul;165(1):97-105

- Bihan H, Baudin E, Meas T, Leboulleux S, Al Ghuzlan A, Hannoteaux V, Travagli JP, Valleur P, Guillausseau PJ, Cohen R; for the French Group of Endocrine Tumors (GTE)
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma.
Head Neck. 2011 Jun 17. doi: 10.1002/hed.21763.

- More J, Young J, Reznik Y, Raverot G, Borson-Chazot F, Rohmer V, Baudin E, Coutant R, Tabarin A; Groupe Français des Tumeurs Endocrines (GTE)
Ectopic ACTH syndrome in children and adolescents
J Clin Endocrinol Metab. 2011 May;96(5):1213-22. Epub 2011 Feb 23.

- Vezzosi D, Walter T, Laplanche A, Raoul JL, Dromain C, Ruszniewski P, d'Herbomez M, Guigay J, Mitry E, Cadiot G, Leboulleux S, Lombard-Bohas C, Borson-Chazot F, Ducreux M, Baudin E.
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study.
Int J Biol Markers. 2011 Apr-Jun;26(2):94-101

- Rohmer V, Vidal-Trecan G, Bourdelot A, Niccoli P, Murat A, Wemeau JL, Borson-Chazot F, Schvartz C, Tabarin A, Chabre O, Chabrier G, Caron P, Rodien P, Schlumberger M, Baudin E; Groupe Français des Tumeurs Endocrines.
Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.
J Clin Endocrinol Metab. 2011 Mar;96(3):E509-18.

Publications 2010

- D'Herbomez M, Do Cao C, Vezzosi D, Borzon-Chasot F, Baudin E; groupe des tumeurs endocrines (GTE France)
Chromogranin A assay in clinical practice.
Ann Endocrinol (Paris). 2010 Sep;71(4):274-80. Epub 2010 Jun 9. Review.
 
- Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Ménégaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Delemer B, Beckers A, Bonithon-Kopp
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
C.World J Surg. 2010 Feb;34(2):249-55

Publications 2009

- Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay Choplin H, Chapuis Y, Kraimps JL, Sadoul JL, Tabarin A, Vergès B, Carnaille B, Niccoli-Sire P, Costa A, Calender A; GTE network (Groupe des Tumeurs Endocrines)
Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)
World J Surg. 2009 Jun;33(6):1197-207

Publications 2008

- Cardot-Bauters C, Leteurtre E, Leclerc L, Vantyghem MC, Do Cao C, Wemeau JL, d'Herbomez M, Carnaille B, Barbu V, Pinson S, Pigny P; Groupe d'Etude des Tumeurs Endocrines (GTE
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
Clin Endocrinol (Oxf). 2008 Sep;69(3):506-10. Epub 2008 Mar 10.
 
- Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Vergès B, Chabre O, Calender A; Groupe d'études des Tumeurs Endocrines
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Am J Surg Pathol. 2008 Apr;32(4):534-43.

Publications 2007

- D'Herbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wémeau JL; French Group GTE (Groupe des Tumeurs Endocrines)
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking.
Eur J Endocrinol. 2007 Dec;157(6):749-55.
 
- Goudet P, Bonithon C, Costa A, Cadiot G, Baudin E, Murat A, Delemer B, Tabarin A, Lecomte P, Calender A; Endocrine Tumor Study Group (GTE)
A Multiple endocrine neoplasia type-1 observatory in a French-speaking area. A tool from the Endocrine Tumor study Group (GTE).
Ann Endocrinol (Paris). 2007 Jun;68(2-3):154-9. Epub 2007 Mar 26. Review. French.

Publications 2006

- Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA; French Endocrine Tumor Study Group
Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor ? An analysis of 65 patients from the GTE
World J Surg. 2006 May;30(5):654-62; discussion 663-4.

- Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin Hdu B, Chabre O, Jovenin N, Cadiot G; Groupe des Tumeurs Endocrines (GTE)
Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Am J Gastroenterol. 2006 Feb;101(2):266-73.
 
- Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A, Proye CA.
Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.
Ann Surg. 2006 Feb;243(2):265-72

Publications 2005

- Barbet J, Campion L, Kraeber-Bodéré F, Chatal JF; GTE Study Group.
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma
J Clin Endocrinol Metab. 2005 Nov;90(11):6077-84. Epub 2005 Aug 9.

Publications 2004

- Goudet P, Peschaud F, Mignon M, Nicoli-Sire P, Cadiot G, Ruszniewski P, Calender A, Murat A, Sarfati E, Peix JL, Kraimps JL, Henry JF, Cougard P, Proye C; Groupe des Tumeurs Endocrines.
Gastrinomas in multiple endocrine neoplasia type-1. A 127-case cohort study from the endocrine tumor group (ETG)
Ann Chir. 2004 Apr;129(3):149-55. French

© GTE – Mars 2017